Viemed Healthcare Plans Share Repurchase Program for 2026

Viemed Healthcare, Inc. (Viemed), a leading national provider of technology-driven, home-based healthcare solutions and chronic disease management, has recently announced the authorization of a share repurchase program by its Board of Directors, which will be in effect through March 2027.

Under this program, Viemed has the opportunity to buy back up to 1,930,131 of its common shares, representing about 5% of the total issued and outstanding common shares as of March 4, 2026. The company plans to execute these repurchases through various means, such as open market purchases or block purchases, in compliance with relevant securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934.

Casey Hoyt, Viemed’s Chief Executive Officer, expressed confidence in the company’s abilities, referring to the strength of their cash flows, the robustness of their balance sheet, and their commitment to disciplined capital allocation. Noting the significant milestones reached in 2025, which included record revenue and Adjusted EBITDA, a substantial increase in free cash flow, and minimal net debt at year-end, Hoyt highlighted the importance of this fourth share repurchase program.

The decision to repurchase shares is viewed as opportunistic and value-driven, aligning with Viemed’s broader strategy of balancing capital allocation among repurchasing shares, investing in organic growth, and pursuing targeted acquisitions. With a healthy $13.5 million in cash reserves at the close of 2025 and considerable funding available through credit facilities, Viemed is well-positioned to navigate these priorities while maintaining financial agility.

The price at which Viemed will acquire the common shares will be based on market value at the time of purchase, along with applicable brokerage fees, adhering to permissible pricing under securities laws. While there are no guarantees regarding the number of shares that will ultimately be repurchased, the company retains the flexibility to halt purchases at any point, as long as regulations are followed. Any common shares bought back will be subsequently canceled.

Viemed Healthcare, Inc. specializes in providing home medical equipment and post-acute healthcare services focused on respiratory, chronic care, and women’s health products and services in the U.S. Their approach emphasizes delivering high-quality care within a home setting through a blend of technology-enabled services and personalized clinical support, encompassing therapy, education, and counseling by their team of medical practitioners.

In conclusion, Viemed’s announcement regarding the share repurchase program underscores a strategic move to reinforce shareholder value, capitalize on operational strength, and maintain financial flexibility. Through prudent capital allocation, potential for continued growth in cash flow, and a steadfast commitment to enhancing shareholder returns, Viemed continues to demonstrate its resilience and commitment to sustainable success in the healthcare industry.